Revolution Medicines Ownership | Who Owns Revolution Medicines?
Revolution Medicines Ownership Summary
Revolution Medicines is owned by 14.19% institutional investors, 1.87% insiders, and 83.93% retail investors. Vanguard group is the largest institutional shareholder, holding 8.84% of RVMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.04% of its assets in Revolution Medicines shares.
RVMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Revolution Medicines | 14.19% | 1.87% | 83.93% |
| Sector | Healthcare Stocks | 232.86% | 10.65% | -143.51% |
| Industry | Biotech Stocks | 382.13% | 10.41% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 16.72M | 8.84% | $1.33B |
| Farallon capital management | 14.63M | 7.77% | $683.02M |
| Janus henderson group | 9.48M | 5.68% | $414.78M |
| Wellington management group llp | 9.81M | 5.22% | $458.29M |
| Baker bros. advisors lp | 9.46M | 5.03% | $441.57M |
| Fmr | 9.40M | 5.00% | $439.06M |
| Blackrock funding, inc. /de | 8.93M | 4.72% | $711.01M |
| Nextech invest | 7.60M | 4.56% | $332.47M |
| Nextech invest | 7.60M | 4.04% | $354.97M |
| Paradigm biocapital advisors lp | 6.22M | 3.31% | $290.63M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nextech invest | 7.60M | 54.03% | $354.97M |
| Nextech invest | 7.60M | 53.94% | $332.47M |
| Lunate rsc | 2.20M | 45.54% | $96.06M |
| Lunate capital | 549.05K | 44.36% | $53.40M |
| Park avenue institutional advisers | 5.12K | 40.50% | $407.41M |
| Casdin capital | 2.65M | 10.31% | $123.63M |
| Ah capital management | 2.75M | 9.20% | $128.36M |
| Boxer capital | 4.28M | 8.75% | $166.09M |
| Paradigm biocapital advisors lp | 6.22M | 8.27% | $290.63M |
| Alphabet | 4.13M | 8.01% | $193.02M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 9.48M | 0.21% | 3.35M |
| General atlantic | 2.47M | 3.47% | 2.47M |
| Norges bank | 2.46M | 0.02% | 2.46M |
| Lunate rsc | 2.20M | 45.54% | 2.20M |
| Ubs group | 3.09M | 0.04% | 2.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jpmorgan chase | 421.63K | 0.00% | -2.08M |
| Lunate capital | 549.05K | 44.36% | -1.65M |
| Balyasny asset management | - | - | -1.30M |
| Bvf inc/il | 3.97M | 7.52% | -1.01M |
| Price t rowe associates inc /md/ | 3.87M | 0.02% | -828.26K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| General atlantic | 2.47M | 3.47% | 2.47M | $115.56M |
| Norges bank | 2.46M | 0.02% | 2.46M | $195.57M |
| Lunate rsc | 2.20M | 45.54% | 2.20M | $96.06M |
| Tcg crossover management | 436.47K | 1.00% | 436.47K | $20.38M |
| Lord, abbett | 399.48K | 0.10% | 399.48K | $31.82M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Tortoise investment management | -1.00 |
| Activest wealth management | -1.00 |
| American capital advisory | -6.00 |
| Principal securities | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 114 | -66.47% | 26,858,113 | -86.01% | 14 | 0.14% | 69 | -62.70% | 24 | -72.41% |
| Sep 30, 2025 | 114 | -63.34% | 30,120,079 | -83.73% | 16 | 0.17% | 59 | -64.88% | 31 | -63.95% |
| Jun 30, 2025 | 318 | 8.53% | 190,637,976 | -0.22% | 101 | 0.98% | 170 | 18.06% | 89 | - |
| Mar 31, 2025 | 25 | -91.50% | 35,140,611 | -81.80% | 18 | 0.14% | 15 | -92.11% | 6 | -89.09% |
| Dec 31, 2024 | 277 | 5.73% | 184,740,316 | 9.37% | 110 | 1.08% | 179 | 20.95% | 52 | -16.13% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.98M | 3.04% | 148.91K |
| Vanguard US Total Market Shares ETF | 4.74M | 2.55% | 4.24K |
| BB Biotech AG Ord | 4.37M | 2.37% | -484.46K |
| iShares Russell 2000 ETF | 4.27M | 2.29% | - |
| Vanguard Small Cap Index | 4.35M | 2.21% | 175.10K |
| Fidelity Growth Compy Commingled Pl S | 3.39M | 1.71% | -70.00K |
| Fidelity Growth Company Fund | 2.51M | 1.27% | - |
| Vanguard Small Cap Growth Index Inv | 2.43M | 1.24% | 117.05K |
| Vanguard Health Care Inv | 2.38M | 1.20% | -1.25M |
| Janus Inst Mid Cap Growth CF | 2.09M | 1.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 15, 2026 | GOLDSMITH MARK A | See Remarks | Sell | $18.01M |
| Mar 25, 2026 | Mancini Anthony | See Remarks | Sell | $167.80K |
| Mar 25, 2026 | Mancini Anthony | See Remarks | Sell | $2.01M |
| Mar 25, 2026 | Mancini Anthony | See Remarks | Sell | $294.52K |
| Mar 25, 2026 | Mancini Anthony | See Remarks | Sell | $1.06M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 31 |
| 2025 Q4 | - | 14 |
| 2025 Q3 | - | 13 |
| 2025 Q2 | - | 7 |
RVMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools